EVOLVE (@evolve_eolc) 's Twitter Profile
EVOLVE

@evolve_eolc

A collaborative, trainee-led national audit focused on end of life care in ACLD. Thanks to BSG, BASL and ToRcH-UK for their support and endorsement

ID: 1554119380304334858

linkhttp://redcap.link/evolve calendar_today01-08-2022 14:58:41

106 Tweet

320 Followers

332 Following

EVOLVE (@evolve_eolc) 's Twitter Profile Photo

There’s just over🚨TWO WEEKS🚨to go before the data entry deadline (28th April). Thank you to all of the sites who have helped us achieved our goal of representation nationwide. Here’s to putting #EndOfLifeCare in advanced chronic liver disease on the map! 📌🗺

There’s just over🚨TWO WEEKS🚨to go before the data entry deadline (28th April).
 
Thank you to all of the sites who have helped us  achieved our goal of representation nationwide.

Here’s to putting #EndOfLifeCare in advanced chronic liver disease on the map! 📌🗺
Seb (@ibdseb) 's Twitter Profile Photo

This is remarkable achievement from the team Emma & Dan Maggs I am proud that BSG Research supported this work as part of the BSG #research strategy 👀 put for the next project in #IBD , #Liver , #Colonca Collaboration with @BiCOPS - thank you Tom Pinkney

EVOLVE (@evolve_eolc) 's Twitter Profile Photo

With one week to go, we’re thrilled to have passed the ✨600 patient✨mark! Thanks again to all our contributors for making this collaborative achievement possible

EVOLVE (@evolve_eolc) 's Twitter Profile Photo

It’s the🚨FINAL WEEK🚨to submit your data for EVOLVE (deadline Friday 28th April) We currently have: ✔️83 active hospital sites ✔️620 eligible patients so far Has your site completed yet?

@BiCOPS (@bicops) 's Twitter Profile Photo

The EVOLVE database closes to new records TOMORROW with over 3,000 patients reviewed for eligibility! A massive thank you to all our sites, Emma, Dan Maggs and BSG Research for making the project happen.

BSG Trainees (@bsgtrainees) 's Twitter Profile Photo

An excellent example of the power of national trainee collaboration and how corporate authorship can be used successfully. We hope to see ToRcH-UK going from strength to strength 📈

An excellent example of the power of  national trainee collaboration and how corporate authorship can be used successfully. We hope to see <a href="/uk_torch/">ToRcH-UK</a> going from strength to strength 📈
EVOLVE (@evolve_eolc) 's Twitter Profile Photo

Are you joining us at BSG LIVE? 🎤 Want to know what proportion of patients with decompensated cirrhosis received quality palliative care in their last year of life? 💭 Head to Hall 1A on Tuesday AM to hear about the results of our trainee-led national audit 📉📊📈 #BSGLIVE23

Are you joining us at BSG LIVE? 🎤

Want to know what proportion of patients with decompensated cirrhosis received quality palliative care in their last year of life? 💭

Head to Hall 1A on Tuesday AM to hear about the results of our trainee-led national audit 📉📊📈

#BSGLIVE23
EVOLVE (@evolve_eolc) 's Twitter Profile Photo

Thank you to BSG Research (and our eternal cheerleader Seb!) for their funding and support, without which none of this would have been possible. It was a privilege to share our early data and show what can be achieved by trainee-led initiatives. #BSGLIVE23

Thank you to <a href="/ResearchBsg/">BSG Research</a> (and our eternal cheerleader <a href="/ibdseb/">Seb</a>!) for their funding and support, without which none of this would have been possible. It was a privilege to share our early data and show what can be achieved by trainee-led initiatives. 

#BSGLIVE23
Debbie Shawcross (@debbieshawcros1) 's Twitter Profile Photo

EVOLVE highlighting that we don’t talk to our patients about #prognosis. Only 46.9% patients with adv. #cirrhosis are referred to #palliativecare and 79.1% of patients with #decompensation are referred only during their terminal admission. We must do better. #bsglive2023

<a href="/EVOLVE_EOLC/">EVOLVE</a> highlighting that we don’t talk to our patients about #prognosis. Only 46.9% patients with adv. #cirrhosis are referred to #palliativecare and 79.1% of patients with #decompensation are referred only during their terminal admission. We must do better. #bsglive2023
Frontline Gastro (@frontgastro_bmj) 's Twitter Profile Photo

Palliative care is really important - lots of work nationally going to identify how we improve this like EVOLVE . Principles are about managing symptoms and improving quality of life and referral to palliative care formally can help support this

Palliative care is really important - lots of work nationally going to identify how we improve this like <a href="/EVOLVE_EOLC/">EVOLVE</a> . Principles are about managing symptoms and improving quality of life and referral to palliative care formally can help support this
Ben Hudson (@hudsonbe81) 's Twitter Profile Photo

BASL BSG end of life SIG meeting in Bristol 19th October ✅Free to attend (email [email protected]) ✅Fantastic programme including REDUCe2 EVOLVE and international speakers ✅Great for UK networking and collaboration Tell your friends & please RT!

<a href="/basl_events/">BASL</a> <a href="/BritSocGastro/">BSG</a> end of life SIG meeting in Bristol 19th October

✅Free to attend (email matt@basl.org.uk)
✅Fantastic programme including <a href="/REDUCe2study/">REDUCe2</a> <a href="/EVOLVE_EOLC/">EVOLVE</a> and international speakers
✅Great for UK networking and collaboration

Tell your friends &amp; please RT!
EVOLVE (@evolve_eolc) 's Twitter Profile Photo

Thank you to Ben Hudson for the opportunity to share our results at the BASL End of Life SIG meeting today. Plenty of discussion and thoughts for the future 🙌🏼 Keep your eyes peeled for publication of the full data over the coming months 👀 #palliativehepatology BASL

Ellen Haire (@drellenhaire) 's Twitter Profile Photo

🔔 Delighted our paper is now out. Would love to hear your thoughts 🔔 Andrew Yeoman Simon Noble Dr Mark Wright Clea Atkinson BMJ SPCare Supportive and palliative care needs in advanced non-malignant liver disease: systematic review spcare.bmj.com/content/early/…

Sarah Bowers (@sarahpbowers) 's Twitter Profile Photo

Fantastic review highlighting the burden of palliative care needs in people with advanced chronic liver disease. V timely for our ongoing work in EVOLVE!

EVOLVE (@evolve_eolc) 's Twitter Profile Photo

Thanks to all EVOLVE collaborators who have helped us put #PalliativeCare on the agenda at #EASLCongress. We were pleased to see a session on symptomatic management featured too to highlight this vital area of hepatology 👏🏻 Elliot Tapper #MartaCarol EASLnews #LiverTwitter

Thanks to all EVOLVE collaborators who have helped us put #PalliativeCare on the agenda at #EASLCongress. 

We were pleased to see a session on symptomatic management featured too to highlight this vital area of hepatology 👏🏻 <a href="/ebtapper/">Elliot Tapper</a> #MartaCarol 

<a href="/EASLnews/">EASLnews</a> #LiverTwitter
Lucia Macken (@luciamacken) 's Twitter Profile Photo

Fantastic BASL annual meeting 🙌🏼 BASL end of life SIG meeting upcoming: 7th November 2024 Birmingham Multiprofessional Free attendance Hybrid Contact [email protected] REDUCe2 EVOLVE Cathy Beresford #palliativehepatology #ESLD #EOLC Programme 👇🏼

Fantastic <a href="/basl_events/">BASL</a> annual meeting 🙌🏼  

BASL end of life SIG meeting upcoming:
7th November 2024 
Birmingham 
Multiprofessional 
Free attendance
Hybrid
Contact georgia@basl.org.uk

<a href="/REDUCe2study/">REDUCe2</a> <a href="/EVOLVE_EOLC/">EVOLVE</a> <a href="/CathyJBeresford/">Cathy Beresford</a>  #palliativehepatology #ESLD #EOLC 
Programme 👇🏼